Health Care: Drugs

Medgenics Inc (MDGN: AMEX)

$3.84 0.00 | 0.00%
06/19/13 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 3.84
52 Week High 16.43
52 Week Low 3.66
Avg. Daily Vol. (Mil) 0.03
Beta (3 year) 0.99
Share Related Items
Mkt Cap (Mil) 70.97
Shares Out (Mil) 18.48
Float (Mil) 15.69
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 12.00
Current Ratio 12.40
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 2.49
Price/Cash Flow -3.80
Per Share Data
Earnings -1.40
Sales 0.00
Book Value 1.54
Cash Flow -1.01
Business Summary
Medgenics Inc is a medical technology and therapeutics company engaged in providing sustained protein therapies to treat chronic diseases and conditions.
General Information
555 California Street
Suite 365
San Francisco, CA 94104
www.medgenics.com
Industry : Drugs
Sector: Health Care
Employees: 34
CEO: Andrew Leonard Pearlman
Short Interest
Current Month (Mil) 0.37
Previous Month (Mil) 0.38
Short Interest Ratio (Days) 15.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -55.70
Return on Investments -65.00
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with MDGN

Latest MDGN Headlines from TheStreet

More Financial News for MDGN

Press Releases for MDGN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter